News & AnalysisSatellite Bio lands $110mSatellite Bio, a regenerative medicine company, has raised $110 million in funding.ByIris Dorbian20 April 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs